DSIJ Mindshare

Micro-cap pharma stock announces 1:1 bonus share for the first time ever; don’t miss out on the record date!

Company ranks among the top 5 companies in India for providing the most extensive range of Iodine derivatives in the market

Karan Dsij 2 28152 Article rating: 4.0

The company reported a net profit of Rs. 9.49 crore for FY23, exhibiting a remarkable year-on-year growth of 55.4 per cent when compared to the net profit of Rs. 6.10 crore achieved in FY22

RSS
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR